Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Human Prothrombin Complex - Takeda

Next Previous
Drug Profile

Human Prothrombin Complex - Takeda

Alternative Names: PROPLEX; PROPLEX 600; Prothromplex; Prothromplex 600; Prothromplex 600 IE; Prothromplex 600 SV; Prothromplex 600 TV; Prothromplex 600 UI; Prothromplex NF 600; Prothromplex NF 600 IU; PROTHROMPLEX TOTAL; Prothromplex TOTAL 600; Prothromplex TOTAL 600 IU; Prothromplex Total 600 UI; Prothromplex Total NF; Prothromplex Total NF 600; TAK-330

Latest Information Update: 10 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Takeda
  • Class Antihaemorrhagics; Blood coagulation factors
  • Mechanism of Action Blood coagulation factor replacements; Factor IX stimulants; Factor VII stimulants; Factor X stimulants; Protein C inhibitors; Prothrombin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Haemorrhage
  • Phase III Blood coagulation disorders

Most Recent Events

  • 24 Aug 2022 Phase-III clinical trials in Blood coagulation disorders in Germany, Spain, Portugal, France, Canada, Belgium, Austria (IV) (NCT05156983)
  • 24 Aug 2022 Takeda initiates a phase III trial in Blood coagulation disorder in US (IV, Infusion) (NCT05156983)
  • 25 Jul 2022 Phase-III clinical trials in Blood coagulation disorders in Netherlands (IV) (EudraCT2021-004138-12)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top